China, India and the US will have the world’s largest populations of adults living with overweight and obesity by 2050, ...
A number of sessions on the second day of IPWatchdog LIVE examined the state of U.S. IP policy and the potential for change ...
Pope Francis was up and receiving therapy on Monday after apparently overcoming a setback in his recovery from pneumonia. The ...
A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...
4h
Investor's Business Daily on MSNMeta, Netflix Hold Tough As Tech Tanks. But This Biotech Booms.While Netflix and Meta stock fight to shake off market volatility, Eli Lilly and this biotech stock join them and others on ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.
Cedar Rapids Xavier girls basketball has leaned heavily on one of the state's top players this year and will look to do so ...
We tapped some of Palm Beach’s most stylish men to don Lilly Pulitzer's new threads and dish on their own sartorial ...
The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...
Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results